Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.66 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.66 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.66 |
| ▸ | PDE4A | P27815 | 1/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.66 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.66 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.66 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CA7 | P43166 | 2/20 | 0.56 |
| ▸ | CA9 | Q16790 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4556067 | 0.94 | KDR (0.75) | KDRMEN1KMT2ALMNAEPHX2 | |
| SCHEMBL11185513 | 0.89 | KDR (0.65) | KDRMEN1KMT2ALMNAEPHX2 | |
| Cloflucarban SCHEMBL119821 | 0.88 | KDR (0.88) | KDRMEN1KMT2ALMNAEPHX2 | |
| Cloflucarban SCHEMBL27537485 | 0.88 | KDR (0.88) | KDRMEN1KMT2ALMNAEPHX2 | |
| SCHEMBL10220062 | 0.88 | KDR (0.88) | KDREPHX2EPHX1CA1CA2 | |
| Cloflucarban SCHEMBL28866649 | 0.87 | KDR (0.80) | KDRMEN1KMT2ALMNAEPHX2 | |
| SCHEMBL4548244 | 0.85 | SMN1; SMN2 (0.67) | KDRMEN1KMT2ALMNAEPHX2 | |
| SCHEMBL11831657 | 0.84 | KDR (0.62) | KDRMEN1KMT2ALMNAEPHX2 | |
| SCHEMBL9524746 | 0.84 | CA2 (0.53) | KDRMEN1KMT2ALMNAEPHX2 | |
| SCHEMBL665533 | 0.82 | KDR (0.67) | KDRMEN1KMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1020 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2916820-B1 | DELIVERY OF BIOLOGICALLY-ACTIVE AGENTS USING VOLATILE, HYDROPHOBIC SOLVENTS | ROCHAL TECH LLC (US) | 2023-10-11 | — | — | EP | claimed |
| EP-3677251-B1 | WATER-IN-OIL EMULSION-TYPE STICK-LIKE DEODORANT AGENT | SHINETSU CHEMICAL CO (JP) | 2023-08-16 | — | — | EP | claimed |
| US-11547643-B2 | Water-in-oil emulsion-type stick-shaped deodorant composition | SHTN-ETSU CHEMICAL CO., LTD. (JP) | 2023-01-10 | — | — | US | claimed |
| WO-2021054927-A2 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2021-03-25 | — | — | WO | claimed |
| EP-3263145-B1 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR LOCKING CATHETERS | BECTON DICKINSON CO (US) | 2021-01-20 | — | — | EP | claimed |
| US-20200253843-A1 | WATER-IN-OIL EMULSION-TYPE STICK-SHAPED DEODORANT COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-08-13 | — | — | US | claimed |
| EP-3677251-A1 | WATER-IN-OIL EMULSION-TYPE STICK-LIKE DEODORANT AGENT | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-07-08 | — | — | EP | claimed |
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | SOUTH DAKOTA BOARD OF REGENTS (US) | 2020-02-13 | — | — | US | claimed |
| CN-109862877-A | Cosmetics for skin | 花王株式会社 | 2019-06-07 | — | — | CN | claimed |
| CN-109640927-A | The composition for dermal delivery comprising nano-emulsion and modified layered double hydroxide | H&A帕玛科株式会社 | 2019-04-16 | — | — | CN | claimed |
| EP-0506207-B1 | Pharmaceutical vehicles for reducing transdermal flux | ACCESS PHARMA INC (US) | 1999-11-17 | — | — | EP | claimed |
| WO-1999045771-A1 | TISSUE PAPER HAVING ANTIMICROBIAL SKIN LOTION | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-16 | — | — | WO | claimed |
| US-5891914-A | COMPLEX OF ORGANOSILICON COMPOUND AND ACTIVE MATERIALS | SPECIAL ADVANCED BIOMATERIALS, INC. (US) | 1999-04-06 | — | — | US | claimed |
| EP-0872248-A2 | Pharmaceutical vehicles for reducing transdermal flux | Access Pharmaceuticals, Inc. (US) | 1998-10-21 | — | — | EP | claimed |
| WO-1992017184-A2 | BIOACTIVE TOPICAL SILOXANE COMPOSITIONS HAVING ENHANCED PERFORMANCE AND SAFETY | SPECIAL ADVANCED BIOMATERIALS, INC. (US) | 1992-10-15 | — | — | WO | claimed |
| EP-0506207-A2 | Pharmaceutical vehicles for reducing transdermal flux | CHEMEX PHARMACEUTICALS, Inc. (US) | 1992-09-30 | — | — | EP | claimed |
| US-4895727-A | Using water soluble zinc compound | CHEMEX PHARMACEUTICALS, INC. (US) | 1990-01-23 | — | — | US | claimed |
| EP-0215072-A4 | ANTISEPTIC FLUIDS. | GLUCK BRUNO A | 1990-01-08 | — | — | EP | claimed |
| EP-0215072-A1 | ANTISEPTIC FLUIDS | GLUCK, Bruno Anthony (AU) | 1987-03-25 | — | — | EP | claimed |
| WO-1986005391-A1 | ANTISEPTIC FLUIDS | GLUCK BRUNO A (AU) | 1986-09-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048305-A1 | GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS | GSTK1, GSTO1, GSTM2 | KDR 1275/4885MEN1 1607/4885KMT2A 3630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.